In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

Journal: Science Translational Medicine

Published: 2018-02-21

DOI: 10.1126/scitranslmed.aan3682

Affiliations: 6

Authors: 12

Go to article
Institutions FC
UNC/NCSU Joint Department of Biomedical Engineering (BME), United States of America (USA) 0.33
UNC Center for Nanotechnology in Drug Delivery (CNDD), United States of America (USA) 0.24
UNC Division of Pharmacoengineering and Molecular Pharmaceutics (DPMP), United States of America (USA) 0.24
Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, China 0.08
UNC Department of Microbiology and Immunology, United States of America (USA) 0.08
UNC Department of Medicine, United States of America (USA) 0.02